NATIONAL JEWISH HEALTH
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 1899-01-01
- Employees
- -
- Market Cap
- -
Identification of Epidermal Signatures in Patients With Atopic Dermatitis
- Conditions
- Interventions
- First Posted Date
- 2016-02-11
- Last Posted Date
- 2019-05-10
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 50
- Registration Number
- NCT02680405
- Locations
- ๐บ๐ธ
National Jewish Health and University of Colorado Denver, Denver, Colorado, United States
Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CF
- First Posted Date
- 2015-12-10
- Last Posted Date
- 2019-07-24
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 14
- Registration Number
- NCT02626182
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease (CBD)
- First Posted Date
- 2015-11-13
- Last Posted Date
- 2021-04-29
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 148
- Registration Number
- NCT02604693
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
The Role of JAK2 in Alveolar Macrophages (AM's) in Chronic Beryllium Disease (CBD)
- Conditions
- Interventions
- First Posted Date
- 2015-11-04
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 3
- Registration Number
- NCT02596347
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
COPDGene/Lung Cancer Center Database
- First Posted Date
- 2015-05-15
- Last Posted Date
- 2021-03-04
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 250
- Registration Number
- NCT02445183
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis
- Conditions
- First Posted Date
- 2015-04-17
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 70
- Registration Number
- NCT02419989
- Locations
- ๐บ๐ธ
Nationwide Children's Hospital, Columbus, Ohio, United States
๐บ๐ธUniversity of Pittsburgh, Pittsburgh, Pennsylvania, United States
๐บ๐ธNorthwestern University, Chicago, Illinois, United States
Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis)
- Conditions
- Interventions
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2022-03-21
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 13
- Registration Number
- NCT02323100
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
๐บ๐ธJohns Hopkins University School of Medicine, Baltimore, Maryland, United States
๐บ๐ธChildren's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Tailored Treatment to Enhance Risk Perception in Sleep Apnea
- Conditions
- Interventions
- First Posted Date
- 2014-12-11
- Last Posted Date
- 2021-06-30
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 284
- Registration Number
- NCT02314858
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension
- First Posted Date
- 2014-08-20
- Last Posted Date
- 2021-01-19
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 10
- Registration Number
- NCT02220634
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States
Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension
- First Posted Date
- 2014-06-23
- Last Posted Date
- 2021-01-19
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 7
- Registration Number
- NCT02169752
- Locations
- ๐บ๐ธ
National Jewish Health, Denver, Colorado, United States